Single-dose, dual-antigen VSV-based vaccines protect against Crimean-Congo hemorrhagic fever in two lethal mouse models
Molecular Therapy Advances
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
Single-dose, dual-antigen VSV-based vaccines protect against Crimean-Congo hemorrhagic fever in two lethal mouse models. // Molecular Therapy Advances. – URL: https://www.sciencedirect.com/science/article/pii/S3117387X26002156?dgcid=rss_sd_all
Single-dose, dual-antigen VSV-based vaccines protect against Crimean-Congo hemorrhagic fever in two lethal mouse models. Molecular Therapy Advances. https://www.sciencedirect.com/science/article/pii/S3117387X26002156?dgcid=rss_sd_all
“Single-dose, dual-antigen VSV-based vaccines protect against Crimean-Congo hemorrhagic fever in two lethal mouse models.” Molecular Therapy Advances.
@article{article58976,
title = {Single-dose, dual-antigen VSV-based vaccines protect against Crimean-Congo hemorrhagic fever in two lethal mouse models},
journal = {Molecular Therapy Advances},
url = {https://www.sciencedirect.com/science/article/pii/S3117387X26002156?dgcid=rss_sd_all}
}